139 related articles for article (PubMed ID: 35249033)
1. Predicting the Prognosis of Prostate Cancer Bone Metastasis Using the Bone Scan Index and Hot Spots Calculated Using VSBONEⓇ Bone Scan Index from Tc-99m-Hydroxymethylene Diphosphonate Bone Scintigraphy.
Higashiyama S; Yoshida A; Kawabe J
Urol Int; 2022; 106(9):963-969. PubMed ID: 35249033
[TBL] [Abstract][Full Text] [Related]
2. Study of the Usefulness of Bone Scan Index Calculated From 99m-Technetium- Hydroxymethylene Diphosphonate (
Higashiyama S; Yoshida A; Kawabe J
Curr Med Imaging; 2021; 17(1):89-96. PubMed ID: 32484112
[TBL] [Abstract][Full Text] [Related]
3. Comparison of skeletal segmentation by deep learning-based and atlas-based segmentation in prostate cancer patients.
Motegi K; Miyaji N; Yamashita K; Koizumi M; Terauchi T
Ann Nucl Med; 2022 Sep; 36(9):834-841. PubMed ID: 35773557
[TBL] [Abstract][Full Text] [Related]
4. A computer program to assess the bone scan index for Tc-99m hydroxymethylene diphosphonate: evaluation of jaw pathologies of patients with bone metastases using SPECT/CT.
Ogawa R; Ogura I
Diagn Interv Radiol; 2023 Jan; 29(1):190-194. PubMed ID: 36960615
[TBL] [Abstract][Full Text] [Related]
5. Analytic Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.
Anand A; Morris MJ; Kaboteh R; Båth L; Sadik M; Gjertsson P; Lomsky M; Edenbrandt L; Minarik D; Bjartell A
J Nucl Med; 2016 Jan; 57(1):41-5. PubMed ID: 26315832
[TBL] [Abstract][Full Text] [Related]
6. Flare phenomenon visualized by
Zhang X; Nakajima K; Mizokami A; Horikoshi H; Nishimoto K; Hashine K; Matsuyama H; Takahashi S; Wakabayashi H; Kinuya S
Ann Nucl Med; 2024 Jun; 38(6):428-440. PubMed ID: 38478154
[TBL] [Abstract][Full Text] [Related]
7. Bone scan index on bone scintigraphy and radiation therapy for bone metastases from cancers other than prostate and breast cancers: A retrospective observational study.
Ishibashi N; Maebayashi T; Kimura Y; Okada M
J Cancer Res Ther; 2022; 18(6):1716-1721. PubMed ID: 36412434
[TBL] [Abstract][Full Text] [Related]
8. Assessment of a software for semi-automatically calculating the bone scan index on bone scintigraphy scans.
Yoshida A; Higashiyama S; Kawabe J
Clin Imaging; 2021 Oct; 78():14-18. PubMed ID: 33714920
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of a computer-aided diagnosis system for whole-body bone scintigraphy to detect bone metastasis in breast cancer patients.
Urano M; Maki Y; Nishikawa H; Kawai T; Shiraki N; Shibamoto Y
Ann Nucl Med; 2017 Jan; 31(1):40-45. PubMed ID: 27686468
[TBL] [Abstract][Full Text] [Related]
10. Role of bone scan index in the prognosis and effects of therapy on prostate cancer with bone metastasis: Study design and rationale for the multicenter Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index (PROSTAT-BSI) study.
Nakajima K; Kaneko G; Takahashi S; Matsuyama H; Shiina H; Ichikawa T; Horikoshi H; Hashine K; Sugiyama Y; Miyao T; Kamiyama M; Harada K; Ito A; Mizokami A;
Int J Urol; 2018 May; 25(5):492-499. PubMed ID: 29633398
[TBL] [Abstract][Full Text] [Related]
11. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of bone scan index change over time on automated calculation in bone scintigraphy.
Shintawati R; Achmad A; Higuchi T; Shimada H; Hirasawa H; Arisaka Y; Takahashi A; Nakajima T; Tsushima Y
Ann Nucl Med; 2015 Dec; 29(10):911-20. PubMed ID: 26373556
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of two-dimensional total bone uptake (2D-TBU) and bone scan index (BSI) extracted from active bone metastatic burden on the bone scintigraphy in patients with radium-223 treatment.
Fukai S; Daisaki H; Umeda T; Shimada N; Terauchi T; Koizumi M
Ann Nucl Med; 2024 Jun; 38(6):450-459. PubMed ID: 38517659
[TBL] [Abstract][Full Text] [Related]
14. A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index.
Ulmert D; Kaboteh R; Fox JJ; Savage C; Evans MJ; Lilja H; Abrahamsson PA; Björk T; Gerdtsson A; Bjartell A; Gjertsson P; Höglund P; Lomsky M; Ohlsson M; Richter J; Sadik M; Morris MJ; Scher HI; Sjöstrand K; Yu A; Suurküla M; Edenbrandt L; Larson SM
Eur Urol; 2012 Jul; 62(1):78-84. PubMed ID: 22306323
[TBL] [Abstract][Full Text] [Related]
15. Assessment of bone scans in advanced prostate carcinoma using fully automated and semi-automated bone scan index methods.
Takahashi Y; Yoshimura M; Suzuki K; Hashimoto T; Hirose H; Uchida K; Inoue S; Koizumi K; Tokuuye K
Ann Nucl Med; 2012 Aug; 26(7):586-93. PubMed ID: 22744807
[TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of
Oya T; Ichikawa Y; Nakamura S; Tomita Y; Sasaki T; Inoue T; Sakuma H
Ann Nucl Med; 2023 Jun; 37(6):360-370. PubMed ID: 36947324
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of Tc-99m (V) DMSA for chondrogenic tumors with positive Tc-99m HMDP uptake on bone scintigraphy.
Kobayashi H; Kotoura Y; Hosono M; Sakahara H; Hosono M; Yao ZS; Tsuboyama T; Yamamuro T; Endo K; Konishi J
Clin Nucl Med; 1995 Apr; 20(4):361-4. PubMed ID: 7788996
[TBL] [Abstract][Full Text] [Related]
18. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
19. Relationship between tumor volume and quantitative values calculated using two-dimensional bone scan images.
Hosokawa S; Inoue K; Takahashi Y; Kawakami K; Kano D; Nakagami Y; Fukushi M
Radiol Phys Technol; 2017 Dec; 10(4):496-506. PubMed ID: 28983807
[TBL] [Abstract][Full Text] [Related]
20. New index to assess the extent of bone disease in patients with prostate cancer using SPECT/CT.
Ichikawa H; Shibutani T; Onoguchi M; Taniguchi Y
Ann Nucl Med; 2022 Nov; 36(11):941-950. PubMed ID: 36048347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
